ERC Einstein Rockefeller CUNY Center for AIDS Research

ERC 爱因斯坦洛克菲勒纽约市立大学艾滋病研究中心

• 批准号: 10605259
• 负责人: Vinayaka R. Prasad
• 金额: $ 97.14万
• 依托单位: ALBERT EINSTEIN COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-05-01 至 2027-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10605259
• 关键词: Acquired Immunodeficiency Syndrome; Administrative Supplement; Applications Grants; Award; Catalytic Domain; Clinical; Clinical and Translational Science Awards; Collaborations; Communication; Communities; Consultations; Data; Development; Epidemic; Faculty; Feedback; Funding; Goals; Grant; Growth; HIV; HIV/AIDS; Hepatitis C virus; Individual; Institution; Investments; Learning; Manuscripts; Mental Health; Mentors; Monitor; New York City; Paper; Participant; Pathway interactions; Peer Review; Pilot Projects; Privatization; Process; Publications; Publishing; Research; Research Personnel; Research Priority; Research Project Grants; Sampling; Series; Services; Simplexvirus; Structure; Study Section; Teacher Professional Development; Translational Research; Underrepresented Minority; United States National Institutes of Health; Virus; Work; career; cohort; design; experience; innovation; interest; meetings; member; peer coaching; programs; recruit; skills; success; symposium; synergism; virology; virtual

PROJECT SUMMARY ERC-CFAR: DEVELOPMENTAL CORE The Einstein-Rockefeller-CUNY CFAR (ERC-CFAR) Developmental Core will strive to provide wide-ranging support to nurture and advance the HIV/AIDS research careers of tomorrow’s HIV/AIDS researchers. Our coordinated strategy for this renewal application will be implemented via three specific aims that are centered around early stage investigators (ESIs). In Aim 1, we will employ a multi-faceted mentoring process, which combines individually tailored mentoring plans developed for each ESI and multiple forums to enable ESIs to present their HIV/AIDS research progress to the ERC-CFAR community to garner feedback and develop new collaborations. In Aim 2, we will provide ESIs with opportunities to compete in the peer-reviewed ERC-CFAR catalytic pilot grants and microgrants programs or NIH CFAR administrative supplements opportunities. Aim 3 includes dual goals of enhancing trans- and intra-institutional collaborations and scientific communication. Collaborations will be increased by: (i) recruiting non-AIDS researchers to collaborate with CFAR investigators and by removing obstacles to succeed – both by providing microgrants up to $10K and access to HIV cohorts; (ii) organizing bi-annual virtual K-clubs that are attended by ESIs from Einstein, Rockefeller and CUNY and that include both presentations by successful ESIs and by the ERC-CFAR Developmental and Operational Core leaders about all available CFAR services that can assist ESIs in their research projects and planned grant submissions; and (iii) organizing bi-annual New York City-wide research symposia attended by all NYC HIV/AIDS researchers where individuals from the different major NYC institutions will be selected to present their cutting edge research. We will enhance scientific communication among the investigators of ERC-CFAR via (i) bi-weekly Trans-institutional ERC-CFAR virtual research seminars and biweekly Clinical AIDS Center/ERC-CFAR Grand Rounds; (ii) ERC-CFAR Invited Speaker Seminars; (iii) Monthly Virus Hub meetings consisting of 13 Einstein virologists, which includes 9 faculty members that are focused on research on HIV, HSV or HCV. This provides a special one-stop-shop for all ERC-CFAR ESIs to learn about the latest virological research going on at Einstein. The impressive impact of these highly coordinated and proactive mentoring services by the ERC-CFAR Developmental Core over the past 4 years of funding is demonstrated by accomplishments of our mentored ESIs that include $20.5 million of external grants and 250 publications. The high impact of the ERC-CFAR Developmental Core’s catalytic pilot grant program, which has awarded 14 pilot grants to ESIs so far (0.46 million) from all three participant institutions, is reflected in the fact that they have already garnered up to ~$8.1 million in NIH grants (a return on investment of 17.6) and that they have published over 70 papers.

项目概要 ERC-CFAR：开发核心 爱因斯坦-洛克菲勒-纽约市立大学 CFAR (ERC-CFAR) 发展核心将努力提供广泛的 支持培养和推进未来艾滋病毒/艾滋病研究人员的艾滋病毒/艾滋病研究事业。 该更新申请的协调战略将通过三个具体目标来实施 在目标 1 中，我们将围绕早期研究人员 (ESI) 采用多方面的指导流程。 结合了为每个 ESI 和多个论坛制定的单独定制的指导计划，使 ESI 能够 向 ERC-CFAR 社区展示他们的 HIV/AIDS 研究进展，以收集反馈并开发新的 在目标 2 中，我们将为 ESI 提供参与同行评审的 ERC-CFAR 的机会。 催化试点补助金和小额补助金计划或 NIH CFAR 行政补充机会。 包括加强跨机构和机构内合作以及科学交流的双重目标。 将通过以下方式加强合作：(i) 招募非艾滋病研究人员与 CFAR 调查人员合作 消除成功的障碍——提供高达 1 万美元的小额赠款和接触艾滋病毒人群； (ii) 组织一年两次的虚拟 K 俱乐部，来自爱因斯坦、洛克菲勒和纽约市立大学的 ESI 参加 包括成功的 ESI 以及 ERC-CFAR 开发和运营核心的演讲 领导者了解所有可用的 CFAR 服务，这些服务可以协助 ESI 的研究项目和计划拨款 (iii) 组织一年两次的纽约市范围内的研究研讨会，所有纽约市艾滋病毒/艾滋病患者都参加 研究人员将选择来自纽约市不同主要机构的个人来展示他们的剪辑 我们将通过 (i) 每两周一次的方式加强 ERC-CFAR 研究者之间的科学交流。 跨机构 ERC-CFAR 虚拟研究研讨会和每两周一次的临床艾滋病中心/ERC-CFAR Grand 回合；(ii) ERC-CFAR 邀请演讲者研讨会；(iii) 由 13 位 Einstein 组成的每月病毒中心会议 病毒学家，其中包括 9 名专注于 HIV、HSV 或 HCV 研究的教员。 为所有 ERC-CFAR ESI 提供特殊的一站式服务，以了解 Einstein 正在进行的最新病毒学研究。 ERC-CFAR 这些高度协调和主动的指导服务产生了令人印象深刻的影响 我们指导的 ESI 所取得的成就证明了过去 4 年资金的发展核心 其中包括 2050 万美元的外部赠款和 250 份出版物 ERC-CFAR 的巨大影响。 发展核心的催化试点拨款计划，迄今为止已向 ESI 授予了 14 项试点拨款（0.46 万）来自所有三个参与机构，反映在他们已经获得了高达约 8.1 美元的事实 NIH 拨款 100 万美元（投资回报率为 17.6），并且发表了 70 多篇论文。